Related Experiment Video
Updated: Jun 18, 2025

10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.1K
Neurological manifestations in dogs with acute leukemia
Filipa L S Lyseight1, Charles Pittaway1, Ruth Dennis2
1Oncology Service, Dick White Referrals, Part of Linnaeus Veterinary Limited, Cambridgeshire, United Kingdom.
Frontiers in Veterinary Science
|August 2, 2024
Summary
Neurological signs in dogs can indicate acute leukemia (AL), a rare cancer. This study details findings in six dogs with AL presenting with neurological deficits, showing specific MRI and CSF changes.
Area of Science:
- Veterinary Neurology
- Hematology
- Veterinary Oncology
Background:
- Canine acute leukemia (AL) is a rare hematopoietic neoplasm.
- Neurological abnormalities are frequently reported in dogs with AL, but detailed descriptions are limited.
- Understanding neurological presentations is crucial for diagnosing AL in dogs.
Purpose of the Study:
- To describe the clinical findings in dogs with acute leukemia (AL) presenting with neurological signs as their primary complaint.
- To correlate neurological examination findings with advanced imaging (MRI) and cerebrospinal fluid (CSF) analysis in dogs with AL.
- To identify key diagnostic indicators for canine acute leukemia presenting neurologically.
Main Methods:
- Retrospective search of a private referral hospital database for dogs diagnosed with AL who presented to the neurology department.
- Inclusion criteria: neurological deficits and subsequent AL diagnosis.
- Analysis of neurological examination findings, magnetic resonance imaging (MRI) studies, and cerebrospinal fluid (CSF) analysis.
Main Results:
- Six cases of canine acute leukemia with neurological signs were identified.
- All cases exhibited focal neuroanatomical localization (brain or spinal cord) on examination.
- MRI revealed infiltrative central nervous system (CNS) patterns, abnormal meningeal enhancement, and bone marrow signal changes. CSF analysis showed increased protein and non-specific pleocytosis, with no malignant cells detected.
Conclusions:
- Canine acute leukemia can present with focal neurological deficits.
- Characteristic MRI findings include CNS infiltration and bone marrow changes.
- Increased CSF protein with negative cytology is observed in neurologically affected dogs with AL.
Related Concept Videos
Disorders of Leukocytes
924
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
924
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
157
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
157

